The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field

The clinical evaluation of convalescent plasma (CP) for the treatment of Ebola virus disease (EVD) in the current outbreak, predominantly affecting Guinea, Sierra Leone, and Liberia, was prioritized by the World Health Organization in September 2014. In each of these countries, nonrandomized compara...

Descripción completa

Detalles Bibliográficos
Autores principales: van Griensven, Johan, De Weiggheleire, Anja, Delamou, Alexandre, Smith, Peter G., Edwards, Tansy, Vandekerckhove, Philippe, Bah, Elhadj Ibrahima, Colebunders, Robert, Herve, Isola, Lazaygues, Catherine, Haba, Nyankoye, Lynen, Lutgarde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678103/
https://www.ncbi.nlm.nih.gov/pubmed/26261205
http://dx.doi.org/10.1093/cid/civ680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678103/
https://www.ncbi.nlm.nih.gov/pubmed/26261205
http://dx.doi.org/10.1093/cid/civ680

Ejemplares similares